• Careers
Contact

Mansfield is a leading healthcare and life sciences strategy consulting firm as ranked by the Financial Times and Vault

We advise on corporate strategy, value creation and commercial due diligence by combining research, modelling and analysis with clinical, scientific and operational knowledge

Selected Clients and Assets we have worked on

Our Latest Insights

Expert analysis across healthcare, life sciences, pharma, social care and digital

A Healthcare Investor’s Guide to “AI Exposure”
A human hand and robotic hand reach toward each other against a blue technological background, with the human hand displaying healthcare symbols including a medical cross, while the robot hand shows
A Healthcare Investor’s Guide to “AI Exposure”
Investment
Pet Food 2036: Growth and Disruption in Cat and Dog Food
A white pet food bowl containing brown kibble sits on a wooden floor, with a person's hand visible in the background holding what appears to be a leash.
Pet Food 2036: Growth and Disruption in Cat and Dog Food
Animal Health
Radiopharmaceuticals – where hot molecules meet cold capital
A blister pack of white round pills or tablets against a bright red-orange gradient background.
Radiopharmaceuticals – where hot molecules meet cold capital
Therapeutic Products and Innovation
GLP-1 2.0: Where the next wave of value will be created
A red label reading
GLP-1 2.0: Where the next wave of value will be created
Therapeutic Products and Innovation
Investing in the Mind: Why Tech-Enabled Mental Health is a Private Equity Priority
A woman with blonde hair wearing a white t-shirt holds her hands together in a prayer or meditation pose, with pink nail polish visible and a smartwatch on her wrist.
Investing in the Mind: Why Tech-Enabled Mental Health is a Private Equity Priority
Health & Care
Spanish PE Deals: Max Taylor and Pauline Fontaine take a closer look at the most active funds in the market, and what they invest in
A white ambulance with red cross and blue medical symbols is parked in front of a modern medical facility, with traditional Mediterranean-style buildings and cypress trees visible on the hillside in the background.
Spanish PE Deals: Max Taylor and Pauline Fontaine take a closer look at the most active funds in the market, and what they invest in
Investment
Will primary care always be secondary for investors?
A green-painted Village GP Practice storefront with large windows and a medical cross sign, located in a traditional British brick building on a paved street.
Will primary care always be secondary for investors?
Health & Care
Three key lessons for digital health investors from the demise of Babylon Health
A tablet displaying medical interface with patient profile, DNA helix, and health data sits on a wooden desk alongside medical supplies including pill blister packs, notebooks, and a teal coffee mug, with a medical chart visible on the wall behind.
Three key lessons for digital health investors from the demise of Babylon Health
Health & Care
A Quick Update on NHS Waiting Lists
A minimalist office workspace showing a cork board with two data visualization charts (bar chart and line graph) clipped with blue binder clips, alongside an hourglass icon on the wall and a desk surface with a clipboard and stack of folders.
A Quick Update on NHS Waiting Lists
Health & Care
The Evolving Roles of CDMOs
Laboratory equipment including a bioreactor vessel with blue solution, glass vials with red caps, capsule medications in blister packs, a digital control device with blue screen, and a red sample tray arranged on a white laboratory bench.
The Evolving Roles of CDMOs
Investment
View all

News & Insights

Healthcare news, data and analysis

Via Investors in Healthcare

A consortium of funds led by CVC and GBL have entered into binding agreements for the launch of a voluntary cash tender offer for all outstanding ordinary shares of Euronext […]
Italy: CVC and GBL to top-up shareholding of Recordati in take-private bid
22 May 2026
M&A ,
Manufacturing – Generics ,
Manufacturing – Specialty Pharma ,
News ,
Pharma
Neobiomics, a Swedish life science company focused on improving outcomes for preterm infants through evidence-based nutritional products, has received an investment led by HealthCap, a specialist provider of life sciences […]
Sweden: HealthCap invests in Neobiomics to support continued growth in neonatal care
22 May 2026
Life Sciences ,
News ,
Venture ,
Emma Höglund ,
HealthCap
Full-Life Technologies, a clinical stage radiotherapeutics company with operations in Belgium, Germany, and China, has raised US$150m led by Vivo Capital. Vivo was joined in the financing package, consisting of […]
Belgium: Full-Life Technologies raises US$150m to advance clinical stage assets
22 May 2026
Life Sciences ,
Medtech – Diagnostics ,
News ,
Venture ,
Belgium
Central London’s private healthcare market is entering a more nuanced phase of its post‑pandemic cycle. Growth has not disappeared, but the easy gains of the Covid rebound have passed, leaving […]
Ted Townsend on London’s Private Healthcare reset
21 May 2026
Analysis ,
Healthcare ,
Hospitals and Clinics ,
News ,
Real Assets
HIG Bayside Capital Europe, the European special situations and capital solutions affiliate of US-based alternative investment firm, HIG Capital, is providing a £90m (US$121m) unitranche term loan Lifeways Group, the […]
UK: HIG Bayside Capital Europe completes refinancing of Lifeways Group
20 May 2026
Complex Behavioural Care ,
Debt ,
Healthcare ,
Mental Health ,
News
German healthcare technology company, Eterno, has secured a significant investment from Germany-based growth investor, Verdane, in support of the expansion of its AI-native platform for outpatient care. The investment underscores […]
Germany: Verdane supports Eterno’s platform expansion with significant investment
20 May 2026
Life Sciences ,
Medtech – Healthcare IT ,
News ,
Venture ,
Dominik Schwarz
London-based European specialist healthcare investor, GHO, and CBC Group, an Asian healthcare-focused asset manager, are merging to create the world’s largest dedicated healthcare investment manager, with over US$21bn in AUM. […]
UK/Singapore: GHO and CBC merging to create world’s largest healthcare investor
20 May 2026
Healthcare ,
Life Sciences ,
M&A ,
News ,
Pharma
Adragos Pharma, a Germany-based global CDMO, has appointed Konstantinos (Kostas) Rengis as its new CEO, succeeding company founder and CEO for the last six years, Dr Andreas Raabe. Raabe will […]
Germany: Adragos Pharma appoints Kostas Rengis as CEO
19 May 2026
News ,
People ,
Pharma ,
Services – CRO/CMO/CDMO ,
Adragos Pharma
Capital A, a Netherlands-based investor in companies in the Netherlands, Belgium, and Germany, has announced the close of Capital A Fund V, securing €515m of investor commitments. The Fund was […]
Netherlands: Capital A secures €515m for Fund V
19 May 2026
Healthcare ,
News ,
Venture ,
Capital A ,
Jones Day
Lauxera Capital Partners has closed its second growth fund at €520m (US$605m), surpassing its €500m hard cap and nearly doubling the size of its debut vehicle, as investor appetite continues […]
Lauxera doubles down on European Healthtech scale-up with €520m Fund II close
19 May 2026
Diagnostics ,
Digital Health/Healthtech ,
Healthcare ,
Life Sciences ,
Medtech – Diagnostics
EQT has been selected by the European Commission and fellow founding investors as the preferred investment adviser and fund manager for the Scaleup Europe Fund, a fund – anchored in […]
Europe: EQT selected to lead the Scaleup Europe Fund
19 May 2026
Life Sciences ,
Medtech – Diagnostics ,
Medtech – Healthcare IT ,
Medtech – Hospital Equipment ,
Medtech – Medical Devices and Implants
Cheplapharm, a family-run pharmaceutical company headquartered in Germany, specialising in the development, marketing, and distribution of branded pharmaceutical products, is aligning its management board for the company’s next phase of growth. As part of […]
Germany: Cheplapharm aligns management board for next phase of growth
18 May 2026
News ,
People ,
Pharma ,
Services – CRO/CMO/CDMO ,
Cheplapharm
Finland-based Mehiläinen, the leading provider of specialised medical care in the Nordic countries, is acquiring Sweden-based Aleris, a specialised medical care provider focusing on elective surgery, mental health services and […]
Sweden: Mehiläinen expands to Norway and Denmark and adds in Sweden with acquisition of Aleris from Triton
18 May 2026
Healthcare ,
Hospitals and Clinics ,
M&A ,
News ,
Agnes Pigg
US-based Blue Mountain, a leader in GMP-compliant Enterprise Asset Management (EAM) software for life sciences, has acquired Ireland-based CompuCal Calibration Solutions, a SaaS AI company providing calibration and maintenance management software across Europe. The […]
Ireland: Five Arrows-backed Blue Mountain acquires CompuCal
18 May 2026
Buy Out ,
Life Sciences ,
M&A ,
Medtech – Healthcare IT ,
News
Water Street Healthcare Partners has held the first and final close of its sixth private equity fund at US$1.9bn. Fund VI was oversubscribed and closed at its hard cap. With […]
US: Water Street Healthcare Partners holds first and final close of Fund VI at US$1.9bn
18 May 2026
Buy Out ,
Diagnostics ,
Healthcare ,
Life Sciences ,
Medtech – Diagnostics
Dirk Scholz has taken up his new role as CFO of the Sanner Group, a Germany-based global healthcare packaging and medical device CDMO. He succeeds Henrik Bøggild, who left Sanner after […]
Germany: Sanner Group appoints Dirk Scholz as new CFO
15 May 2026
News ,
People ,
Pharma ,
Services – CRO/CMO/CDMO ,
Dirk Scholz
Domitille de Vienne has joined France-based Andera Partners as a director within its MidCap team, focusing on private equity investments in France. She joins from specialist PE and credit platform, […]
France: Domitille de Vienne joins Andera Partners
14 May 2026
Buy Out ,
Healthcare ,
Life Sciences ,
News ,
People
Spire Healthcare has received a non-binding proposal from Toscafund Asset Management, the UK hospital group’s second largest shareholder, regarding a possible cash offer of 250 pence per share for the […]
UK: Toscafund makes £1bn bid for Spire Healthcare
14 May 2026
Healthcare ,
Hospitals and Clinics ,
M&A ,
News ,
Spire Healthcare
UroMems, a France-based global company developing implantable mechatronics technology to treat stress urinary incontinence (SUI), has raised a US$60m investment from US PE firm Ajax Health. It is the largest […]
France: Ajax Health invests US$60m in UroMems in support of clinical trials in US and France
14 May 2026
Life Sciences ,
Medtech – Medical Devices and Implants ,
News ,
Venture ,
Ajax Health
CordenPharma, a Swiss-based full-service CDMO of APIs, lipid excipients, drug products and packaging, has appointed Marc Augustin as CFO. Augustin joins from PolyPeptide where he spent over two years as […]
Switzerland: CordenPharma appoints Marc Augustin as CFO
13 May 2026
News ,
People ,
Pharma ,
Services – CRO/CMO/CDMO ,
CordenPharma
Newcore Capital, the B-Corp, UK-focussed real estate investment manager specialising in social infrastructure, has achieved a first institutional close for the latest fund within its flagship value-add series, Newcore Strategic Situations VI. The […]
UK: Newcore Capital achieves first close of Strategic Situations Fund VI at £150m
13 May 2026
Education ,
Healthcare ,
News ,
Real Assets ,
Social Care
The UK Competition and Markets Authority’s (CMA) scrutiny of US healthcare REIT Welltower’s acquisition of more than 600 operational UK care homes could become a defining moment for consolidation in […]
UK: CMA’s scrutiny of Welltower’s UK care home acquisitions could become defining moment for consolidation in adult social care
13 May 2026
Analysis ,
Care Homes ,
Legal ,
M&A ,
M&A Deals
CVC Capital Partners has announced the appointment of John Hourican as CFO, effective 1 September, succeeding Fred Watt, who will retire from CVC after almost 20 years with the firm. […]
UK: CVC appoints John Hourican as CFO
12 May 2026
Buy Out ,
News ,
People ,
CVC Capital Partners ,
Fred Watt
CellCentric, a clinical-stage biotechnology company, has completed an oversubscribed US$220m Series D financing led by Venrock Healthcare Capital Partners, with participation from Fidelity Management & Research Company, Sofinnova Partners and […]
UK: CellCentric raises US$220m in oversubscribed Series D financing
12 May 2026
Manufacturing – Specialty Pharma ,
News ,
Pharma ,
Venture ,
American Cancer Society
Knight Frank’s latest report on UK healthcare development opportunities presents a sector at an inflection point. After several years of subdued activity, driven by build cost inflation, tighter funding conditions […]
Unlocking the next phase of growth in UK healthcare real estate
11 May 2026
Analysis ,
Care Homes ,
News ,
Real Assets ,
Retirement Housing